Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Appointed CFO
Quarterly results
Appointed director
|
|
180 DEGREE CAPITAL CORP. (TURN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/27/2017 |
8-K
| Quarterly results |
| 03/24/2017 |
8-K
| Form 8-K - Current report |
| 01/23/2017 |
8-K
| Form 8-K - Current report |
| 01/09/2017 |
8-K
| Form 8-K - Current report |
| 12/20/2016 |
8-K
| Form 8-K - Current report |
| 11/14/2016 |
8-K
| Other Events |
| 07/12/2016 |
8-K
| Form 8-K - Current report |
| 06/30/2016 |
8-K
| Form 8-K - Current report |
| 06/22/2016 |
8-K
| Form 8-K - Current report |
| 06/08/2016 |
8-K
| Form 8-K - Current report |
| 06/06/2016 |
8-K
| Form 8-K - Current report |
| 06/01/2016 |
8-K
| Form 8-K - Current report |
| 05/31/2016 |
8-K
| Form 8-K - Current report |
| 05/03/2016 |
8-K
| Form 8-K - Current report |
| 04/20/2016 |
8-K
| Form 8-K - Current report |
| 04/20/2016 |
8-K
| Form 8-K - Current report |
| 04/06/2016 |
8-K
| Form 8-K - Current report |
| 03/31/2016 |
8-K
| Form 8-K - Current report |
| 03/15/2016 |
8-K
| Form 8-K - Current report |
| 03/09/2016 |
8-K
| Form 8-K - Current report |
| 02/26/2016 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/16/2016 |
8-K
| Other Events, Financial Statements and Exhibits|
Docs:
|
"SAVE THE DATE: D-WAVE SYSTEMS, HZO AND METABOLON TO PRESENT AT HARRIS & HARRIS GROUP’ S ANNUAL MEETING, TUESDAY JUNE 7, 2016, THE NEW YORK GENOME CENTER —February 16, 2016—Harris & Harris Group, Inc. , an investor in transformative companies enabled by disruptive science, announced today that it will be hosting a morning of presentations from three of its portfolio companies, D-Wave Systems, Inc., HZO. Inc., and Metabolon, In. on Tuesday, June 7, 2016, at the New York Genome Center, 101 Ave of the Americas, 10013, from 8:30 a.m. to 12:30 p.m. Members of management will also present an update on Harris & Harris Group’ s corporate strategy. Employees of the New York Genome Center will also be on hand to provide tours of the facility to interested attendees. These presentations will be follow..." |
|
| 01/21/2016 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 12/28/2015 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 12/04/2015 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/09/2015 |
8-K
| Other Events, Financial Statements and Exhibits |
| 10/27/2015 |
8-K
| Other Events, Financial Statements and Exhibits |
| 10/02/2015 |
8-K
| Other Events, Financial Statements and Exhibits|
Docs:
|
"Harris & Harris Group Announces Receipt of Milestone Payment from Acquisition of Molecular Imprints by Canon —October 2, 2015—Harris & Harris Group, Inc. , an investor in transformative companies enabled by disruptive science, is pleased to report that it received payment of approximately $800,000 following achievement of a certain undisclosed milestone associated with the acquisition of its former portfolio company, Molecular Imprints, Inc., by Canon, Inc. of Tokyo, Japan, in April 2014. This payment increases its total gross proceeds from the sale to approximately $7.8 million, including amounts held in escrow. Harris & Harris Group could receive an additional $900,000 upon the achievement of an additional milestone. These proceeds and potential future proceeds are in addition to the app..." |
|
| 08/10/2015 |
8-K
| Other Events, Financial Statements and Exhibits |
| 07/22/2015 |
8-K
| Other Events, Financial Statements and Exhibits|
Docs:
|
"Harris & Harris Group Portfolio Company, Bridgelux, Enters into Agreement to be Acquired by an Investment Group —July 22, 2015—Harris & Harris Group, Inc. , an investor in transformative companies enabled by disruptive science, notes that its portfolio company, Bridgelux, Inc., has entered into a definitive agreement to be acquired by an investment group led by the China Electronics Corporation and ChongQing Linkong Development Investment Company. Established in 1989, CEC controls 61 second-level subsidiaries, including 13 listed holding companies. Harris & Harris Group invested a total of $5.4 million in Bridgelux, beginning with its initial investment in 2005 and valued its securities of the company at $3.5 million as of March 31, 2015. Harris & Harris Group expects to receive cash proce..." |
|
| 06/05/2015 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 06/05/2015 |
8-K
| Other Events, Financial Statements and Exhibits |
| 05/06/2015 |
8-K
| Other Events, Financial Statements and Exhibits|
Docs:
|
"HARRIS & HARRIS GROUP PORTFOLIO COMPANY OPGEN RAISES $17.1 MILLION IN INITIAL PUBLIC OFFERING – May 6, 2015 – Harris & Harris Group, Inc. , notes its portfolio company, OpGen, Inc., announced yesterday the pricing of its initial public offering of 2,850,000 units, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock, at a combined price to the public of $6.00 per unit. All of the units are being offered by OpGen. OpGen's common stock and warrants have been approved for listing on the NASDAQ Capital Market. Each of the common stock and warrants began trading separately on May 5, 2015, under the symbols "OPGN" and "OPGNW," respectively. Each warrant will be immediately exercisable upon issuance for one share of common stock at an exercise..." |
|
| 04/08/2015 |
8-K
| Other Events, Financial Statements and Exhibits|
Docs:
|
"HARRIS & HARRIS GROUP PORTFOLIO COMPANY OPGEN FILES AMENDED REGISTRATION STATEMENT FOR PROPOSED PUBLIC OFFERING – April 8, 2015 – Harris & Harris Group, Inc. , notes its portfolio company, OpGen, Inc., filed an amended registration statement on Form S-1 with the U.S. Securities and Exchange Commission on April 6, 2015, relating to its proposed initial public offering of its common stock. Maxim Group LLC is acting as the sole book-running manager for the proposed OpGen offering. This offering will be made only by means of a prospectus. A copy of the preliminary prospectus may be obtained from Maxim, , 2nd Floor, , 10174, 895-3666. A registration statement relating to these securities has been filed with the U.S. Securities and Exchange Commission but has not yet become effective. These secu..." |
|
|
|
|